Citations Report

Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.

Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.

Pawe?czyk, Tomasz, Marta Grancow-Grabka, Natalia ?urner, and Agnieszka Pawe?czyk. "Omega-3 fatty acids reduce cardiometabolic risk in first-episode schizophrenia patients treated with antipsychotics: Findings from the OFFER randomized controlled study." Schizophrenia Research 230 (2021): 61-68.

Wang, Zhichao, Ping Li, Dianyuan Chi, Tong Wu, Zubing Mei, and Guangcheng Cui. "Association between C-reactive protein and risk of schizophrenia: an updated meta-analysis." Oncotarget 8, no. 43 (2017): 75445.

Wulsin, Lawson R., Thomas J. Blom, Michelle Durling, Jeffrey A. Welge, Melissa P. DelBello, Caleb M. Adler, Robert K. McNamara, and Stephen M. Strakowski. "Cardiometabolic risks and omega?3 index in recent?onset bipolar I disorder." Bipolar disorders 20, no. 7 (2018): 658-665.

van Velzen, Laura S., Lianne Schmaal, Yuri Milaneschi, Marie-Jose van Tol, Nic JA van der Wee, Dick J. Veltman, and Brenda WJH Penninx. "Immunometabolic dysregulation is associated with reduced cortical thickness of the anterior cingulate cortex." Brain, behavior, and immunity 60 (2017): 361-368.

Freeman, Marlene P., Kathryn McInerney, Alexandra Z. Sosinsky, Molly A. Kwiatkowski, and Lee S. Cohen. "Omega-3 fatty acids for atypical antipsychotic-associated hypertriglyceridemia." Annals of clinical psychiatry: official journal of the American Academy of Clinical Psychiatrists 27, no. 3 (2015): 197-202.

De Picker, Livia, Julie Ottoy, Jeroen Verhaeghe, Steven Deleye, Erik Fransen, Lauren Kosten, Bernard Sabbe et al. "State-associated changes in longitudinal [18F]-PBR111 TSPO PET imaging of psychosis patients: evidence for the accelerated ageing hypothesis?." Brain, behavior, and immunity 77 (2019): 46-54.

Robinson, Delbert G., Juan A. Gallego, Majnu John, Lauren A. Hanna, Jian-Ping Zhang, Michael L. Birnbaum, Jessica Greenberg et al. "A potential role for adjunctive omega-3 polyunsaturated fatty acids for depression and anxiety symptoms in recent onset psychosis: results from a 16 week randomized placebo-controlled trial for participants concurrently treated with risperidone." Schizophrenia research 204 (2019): 295-303.

Kelly, Deanna L., Xin Li, Catherine Kilday, Stephanie Feldman, Sarah Clark, Fang Liu, Robert W. Buchanan, and Leonardo H. Tonelli. "Increased circulating regulatory T cells in medicated people with schizophrenia." Psychiatry research 269 (2018): 517-523.

Samimi, Mansooreh, Mehri Jamilian, Zatollah Asemi, and Ahmad Esmaillzadeh. "Effects of omega-3 fatty acid supplementation on insulin metabolism and lipid profiles in gestational diabetes: Randomized, double-blind, placebo-controlled trial." Clinical Nutrition 34, no. 3 (2015): 388-393.

Skulas-Ray, Ann C., Peter WF Wilson, William S. Harris, Eliot A. Brinton, Penny M. Kris-Etherton, Chesney K. Richter, Terry A. Jacobson et al. "Omega-3 fatty acids for the management of hypertriglyceridemia: a science advisory from the American Heart Association." Circulation 140, no. 12 (2019): e673-e691.

Moody, Grant, and Brian J. Miller. "Total and differential white blood cell counts and hemodynamic parameters in first-episode psychosis." Psychiatry research 260 (2018): 307-312.

Devanarayanan, Sivasankar, Hanumanthappa Nandeesha, Shivanand Kattimani, Siddharth Sarkar, and Jancy Jose. "Elevated copper, hs C-reactive protein and dyslipidemia in drug free schizophrenia: Relation with psychopathology score." Asian journal of psychiatry 24 (2016): 99-102.

Fond, G., N. Resseguier, F. Schürhoff, O. Godin, M. Andrianarisoa, L. Brunel, E. Bulzacka et al. "Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort." European archives of psychiatry and clinical neuroscience 268, no. 6 (2018): 541-553.

Khoury, Rita, and Henry A. Nasrallah. "Inflammatory biomarkers in individuals at clinical high risk for psychosis (CHR-P): State or trait?." Schizophrenia research 199 (2018): 31-38.

Wu, Jing Qin, Yun Long Tan, Shu Ping Tan, Mei Hong Xiu, Zhi Ren Wang, Fu De Yang, Jair C. Soares, and Xiang Yang Zhang. "Altered interleukin-18 levels are associated with cognitive impairment in chronic schizophrenia." Journal of psychiatric research 76 (2016): 9-15.

Wang, Xiuling, Jin Huang, and Fan Zhu. "Human endogenous retroviral envelope protein syncytin-1 and inflammatory abnormalities in neuropsychological diseases." Frontiers in psychiatry 9 (2018): 422.

Mori, Neil, Joseph P. McEvoy, and Brian J. Miller. "Total and differential white blood cell counts, inflammatory markers, adipokines, and the metabolic syndrome in phase 1 of the clinical antipsychotic trials of intervention effectiveness study." Schizophrenia research 169, no. 1-3 (2015): 30-35.

García-Álvarez, Leticia, J. R. Caso, M. P. García-Portilla, L. De la Fuente-Tomás, L. González-Blanco, P. Sáiz Martínez, J. C. Leza, and J. Bobes. "Regulation of inflammatory pathways in schizophrenia: a comparative study with bipolar disorder and healthy controls." European Psychiatry 47 (2018): 50-59.

Rado, Jeffrey. "The complex inter-relationship between diabetes and schizophrenia." Current diabetes reviews 13, no. 3 (2017): 195-212.

Pesce, M., A. Ferrone, A. Rizzuto, R. Tatangelo, I. Iezzi, S. Ladu, S. Franceschelli et al. "The SHP-1 expression is associated with cytokines and psychopathological status in unmedicated first episode schizophrenia patients." Brain, behavior, and immunity 41 (2014): 251-260.